M&A Corner
AmplifyBio Completes Acquisition of Intellectual Property to Offer Non-Viral Gene Editing Services for Clients17 Jul 2023
AmplifyBio has successfully acquired intellectual property (IP) that allows the company to offer non-viral gene-editing services, a significant step in... Continue Reading
|
Apollo Medical Holdings, Inc. Signs Definitive Agreement to Acquire Assets of Texas Independent Providers, Expanding Care Partners Business into Houston17 Jul 2023
Apollo Medical Holdings has entered into a definitive agreement to acquire assets related to Texas Independent Providers (TIP), a primary... Continue Reading
|
Astellas Completes Acquisition of Iveric Bio17 Jul 2023
Astellas Pharma US has completed its acquisition of IVERIC bio, making it a wholly-owned subsidiary of Astellas. The acquisition was... Continue Reading
|
Caribou Biosciences Raises $125M Via Equity Just One Week After Pfizer Invested $25M17 Jul 2023
Caribou Biosciences has released long-term follow-up data from the dose escalation portion of its ANTLER Phase 1 trial of CB-010,... Continue Reading
|
Causaly Secures $60M to Accelerate AI-Powered Biomedical Research17 Jul 2023
Causaly, the leading AI platform for biomedical research, has raised $60 million in Series B funding led by ICONIQ Growth,... Continue Reading
|
Israel Innovation Authority to Invest $31M to Establish R&D Infrastructure Center for Bio-Chips-Based Bio-Devices17 Jul 2023
The Israel Innovation Authority has invested NIS 113 million ($31 million) to establish a center that will provide research and... Continue Reading
|
Wavely Diagnostics Announces New Funding to Accelerate Commercial Launch, Scale Delivery of Only Digital Diagnostics Platform for Childhood Ear Infections17 Jul 2023
Wavely Diagnostics has raised $1.35 million in funding to advance its digital diagnostics platform for virtual pediatric care. The platform,... Continue Reading
|
Caribou Biosciences Commences $100M Public Offering of Shares17 Jul 2023
Caribou Biosciences has initiated a $100 million underwritten public offering of shares, with an option for underwriters to purchase an... Continue Reading
|
CVS Caremark Partners with GoodRx to Expand Low-Cost Drug Access.17 Jul 2023
CVS Caremark has partnered with GoodRx to launch Caremark Cost Saver, offering its members access to lower-cost prescription pricing. Starting... Continue Reading
|
Burjeel Holdings to Launch Rare Disease Research & Development Project ‘NADER’ in Partnership with US-Based BridgeBio Pharma17 Jul 2023
Burjeel Holdings and BridgeBio Pharma have entered into a collaboration agreement to advance the diagnosis and treatment of rare diseases... Continue Reading
|